Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Kairos Pharma Ltd (AMEX: KAPA) closed at $0.54 in the last session, up 3.94% from day before closing price of $0.52. In other words, the price has increased by $3.94 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
We take a closer look at KAPA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.52 and its Current Ratio is at 7.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 25 ’24 when Murali Ramachandran bought 200 shares for $1.59 per share. The transaction valued at 318 led to the insider holds 133,057 shares of the business.
Samuelson Doug bought 2,500 shares of KAPA for $3,750 on Nov 22 ’24. The Chief Financial Officer now owns 60,796 shares after completing the transaction at $1.50 per share. On Nov 20 ’24, another insider, Yu John S, who serves as the CEO and Chairman of the company, bought 4,000 shares for $1.44 each. As a result, the insider paid 5,760 and bolstered with 5,341,837 shares of the company.
Stock Price History:
Over the past 52 weeks, KAPA has reached a high of $4.00, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -26.04%, while the 200-Day Moving Average is calculated to be -57.08%.
Shares Statistics:
A total of 15.83M shares are outstanding, with a floating share count of 7.12M. Insiders hold about 57.73% of the company’s shares, while institutions hold 9.36% stake in the company.
